Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 2.179
Filter
Add more filters

Complementary Medicines
Publication year range
1.
Reprod Sci ; 31(7): 1973-1982, 2024 07.
Article in English | MEDLINE | ID: mdl-38600415

ABSTRACT

Gravity in space can have a negative impact on the reproductive system. Given that the reproductive system is one of vitamin D's objectives, this study will use a simulated microgravity model to evaluate its impact on the rat reproductive system.Twenty-two male Wistar rats were allocated into four groups at random. Under microgravity circumstances, the rats were housed in both special and standard cages. Each group was then separated into two subgroups, one of which received vitamin D3 and the other did not. Blood was drawn twice to determine blood levels of vitamin D3, LH, FSH, and testosterone. Rat testes were isolated for histological analysis, as well as a piece of epididymis for sperm count and morphological examination.Microgravity had a detrimental effect on testicular tissue, resulting in lower serum levels of LH and testosterone (p-value < 0.001). Spermatogenesis was largely inhibited under microgravity. During microgravity conditions, however, vitamin D3 had a good effect on testicular structure, and the total number of sperm. Simulated microgravity affects the male reproductive system, compromising testicular morphology, sperm parameters, and hormonal balance. However, this study shows that vitamin D3 supplementation can act as a preventative strategy, minimizing the negative consequences of microgravity. The beneficial effect of vitamin D3 on testicular health and sperm quality implies that it may be useful in protecting male reproductive function in space-related situations.


Subject(s)
Cholecalciferol , Rats, Wistar , Testis , Testosterone , Weightlessness Simulation , Animals , Male , Cholecalciferol/pharmacology , Cholecalciferol/administration & dosage , Testis/drug effects , Testosterone/blood , Rats , Spermatogenesis/drug effects , Spermatogenesis/physiology , Sperm Count , Luteinizing Hormone/blood , Spermatozoa/drug effects , Follicle Stimulating Hormone/blood
2.
Gynecol Endocrinol ; 39(1): 2247098, 2023 Aug 09.
Article in English | MEDLINE | ID: mdl-37573873

ABSTRACT

BACKGROUND: Anti-Müllerian hormone (AMH) has recently emerged as a promising biomarker for the detection of polycystic ovarian morphology. In polycystic ovary syndrome (PCOS), an elevated level of AMH has been suggested to add value to the Rotterdam criteria in cases of diagnostic uncertainty. In this study, we evaluated the correlation between AMH and PCOS, and the potential role of AMH in PCOS diagnosis. METHODS: A case-control study was performed on a total of 200 females, 100 of which were diagnosed with PCOS as per Rotterdam revised criteria (2003) and 100 as the control (non-PCOS group). Patient medical records were therefore retrieved for clinical, biochemical and ultrasound markers for PCOS diagnosis. Sensitivity, specificity, area under receiver operating characteristic (AUROC) curve, and multivariate linear regression models were applied to analyze our data. RESULTS: Mean serum levels of LH and AMH, and LH/FSH ratio were significantly different between compared groups. In the PCOS group, the mean serum AMH level was 6.78 ng/mL and LH/FSH ratio was 1.53 while those of controls were 2.73 ng/mL and 0.53, respectively (p < .001). The most suitable compromise between 81% specificity and 79% sensitivity was obtained with a cutoff value of 3.75 ng/mL (26.78 pmol/L) serum AMH concentration for PCOS prediction, with an AUROC curve of 0.9691. CONCLUSION: Serum AMH cutoff level of 3.75 ng/mL was identified as a convenient gauge for the prediction of PCOS and an adjuvant to the Rotterdam criteria.


Subject(s)
Anti-Mullerian Hormone , Polycystic Ovary Syndrome , Adult , Female , Humans , Anti-Mullerian Hormone/blood , Follicle Stimulating Hormone/blood , Luteinizing Hormone/blood , Polycystic Ovary Syndrome/blood , Polycystic Ovary Syndrome/diagnosis , Polycystic Ovary Syndrome/pathology , Prolactin/blood , Sensitivity and Specificity , Vitamin D/blood , Case-Control Studies , Menstruation Disturbances/pathology
3.
J Chem Neuroanat ; 123: 102120, 2022 09.
Article in English | MEDLINE | ID: mdl-35718292

ABSTRACT

Demyelinating diseases, such as multiple sclerosis, decrease the quality of life of patients and can affect reproduction. Assisted reproductive therapies are available, which although effective, aggravate motor symptoms. For this reason, it is important to determine how the control of the hypothalamus-pituitary-gonadal axis is affected in order to develop better strategies for these patients. One way to determine this is using animal models such as the taiep rat, which shows progressive demyelination of the central nervous system, and was used in the present study to characterize the expression of gonadotrophin-releasing hormone (GnRH), Kisspeptin, and kisspeptin receptor (Kiss1R) and luteinizing hormone (LH) secretion. The expression of kisspeptin, GnRH, and Kiss1R was determined at the hypothalamic level by immunofluorescence and serum LH levels were determined by ELISA. The expression of kisspeptin at the hypothalamic level showed sexual dimorphism, where there was an increase in males and a decrease in females during oestrus. There was no change in the expression of GnRH or kisspeptin receptor, regardless of sex. However, a decrease in serum LH concentration was observed in both sexes. The taiep rat showed changes in the expression of kisspeptin at the hypothalamic level. These changes are different from those reported in the literature with the use of animals with experimental allergic encephalomyelitis, this is because both animal models represent different degrees of progression of multiple sclerosis. Our results suggest that the effects on the hypothalamus-pituitary-gonadal axis depend on the differences between the demyelinating processes, their progression, and even individual factors, and it is thus important that fertility treatments are individualized to maximize therapeutic effects.


Subject(s)
Demyelinating Diseases , Gonadotropin-Releasing Hormone , Kisspeptins , Multiple Sclerosis , Receptors, Kisspeptin-1 , Animals , Demyelinating Diseases/metabolism , Demyelinating Diseases/pathology , Female , Gonadotropin-Releasing Hormone/biosynthesis , Gonadotropin-Releasing Hormone/metabolism , Hypothalamus/metabolism , Kisspeptins/biosynthesis , Luteinizing Hormone/blood , Male , Multiple Sclerosis/metabolism , Multiple Sclerosis/pathology , Quality of Life , Rats , Receptors, Kisspeptin-1/biosynthesis
4.
Aging Cell ; 21(8): e13656, 2022 08.
Article in English | MEDLINE | ID: mdl-35770332

ABSTRACT

Hypothalamic integrity increasingly is being recognized as a marker of healthy longevity in rodent models. Insight into hypothalamic function in humans with exceptional longevity can be gained via investigation of the hypothalamic-pituitary-testicular (HPT) axis in men with exceptional longevity. This study aimed to characterize the HPT axis function, defined by levels of testosterone (T) and luteinizing hormone (LH), in 84 Ashkenazi Jewish men aged 90-106 years. We found that 94% of men exhibited preserved hypothalamic-pituitary function, as evidenced by either normal testosterone and LH levels (25%) or an appropriate rise in LH in response to aging-related primary testicular dysfunction (69%), a hormone pattern mirroring female menopause. Total T level was not associated with metabolic parameters or survival. These results demonstrate a high prevalence of testicular dysfunction with preserved hypothalamic-pituitary function in men with exceptional longevity. Thus, the role of hypothalamic integrity and HPT axis in healthy aging warrants further investigation.


Subject(s)
Hypothalamus , Longevity , Pituitary Gland , Testis , Aging/blood , Aging/metabolism , Follicle Stimulating Hormone/metabolism , Humans , Hypothalamus/metabolism , Longevity/physiology , Luteinizing Hormone/blood , Luteinizing Hormone/metabolism , Male , Pituitary Gland/metabolism , Testicular Diseases/blood , Testicular Diseases/metabolism , Testis/metabolism , Testosterone/blood , Testosterone/metabolism
5.
Nutrients ; 14(2)2022 Jan 10.
Article in English | MEDLINE | ID: mdl-35057459

ABSTRACT

The effects of synbiotic yogurt supplemented with inulin on the pathological manifestations and gut microbiota-bile acid axis were investigated using a dehydroepiandrosterone (DHEA)-induced polycystic ovary syndrome (PCOS) mice model. Female C57BL/6J mice were injected subcutaneously with DHEA at a dose of 6 mg/100 g BW for 20 days to establish a PCOS mouse model. Then, the PCOS mice were treated with yogurt containing inulin (6% w/w) at 15 mL/kg BW for 24 days. Results showed that supplementation of synbiotic yogurt enriched with inulin to PCOS mice decreased the body weight gain, improved estrus cycles and ovary morphology, and reduced the levels of luteinizing hormone while increasing the levels of follicle-stimulating hormone and interleukin-22 in serum. At the genus level, synbiotic yogurt increased the relative abundance of Lactobacillus, Bifidobacterium, and Akkermansia. PICRUSt analysis indicated that KEGG pathways including bile acid biosynthesis were changed after inulin-enriched synbiotic yogurt supplementation. Synbiotic yogurt enriched with inulin also modulated the bile acid profiles. In conclusion, inulin-enriched synbiotic yogurt alleviated reproductive dysfunction and modulated gut microbiota and bile acid profiles in PCOS mice.


Subject(s)
Gastrointestinal Microbiome , Inulin/administration & dosage , Polycystic Ovary Syndrome/diet therapy , Synbiotics/administration & dosage , Yogurt , Adjuvants, Immunologic , Akkermansia , Animals , Bifidobacterium , Bile Acids and Salts/analysis , Bile Acids and Salts/biosynthesis , Body Weight/physiology , Dehydroepiandrosterone , Estrus/physiology , Female , Follicle Stimulating Hormone/blood , Interleukins/blood , Lactobacillus , Luteinizing Hormone/blood , Mice , Mice, Inbred C57BL , Ovary/anatomy & histology , Polycystic Ovary Syndrome/blood , Polycystic Ovary Syndrome/chemically induced , Interleukin-22
6.
J Ethnopharmacol ; 282: 114594, 2022 Jan 10.
Article in English | MEDLINE | ID: mdl-34480994

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Saffron petal has traditionally been used to treat a variety of diseases, such as gynecological disease such as primary dysmenorrhea and premenstrual tension. Polycystic Ovary Syndrome (PCOS) is a form of gynecological disease that causes amenorrhea, infertility, menopausal and urogenital disorders. This disease may be treated with saffron petals. AIM OF THE STUDY: In this study, the effects of saffron petal extract (SPE) and saffron petal anthocyanins (SPA) on ovarian hormones, steroidogenic enzymes, ovarian dysfunction, regulation of anti-inflammatory genes, and antioxidant factors in female PCOS mice were studied. METHODS AND RESULTS: The PCOS mouse model was induced by testosterone enanthate (TE), and an in vivo evaluation of whether the dietary consumption of SPE and SPA improved the PCOS-like symptoms was conducted. The luteinizing hormone (LH), testosterone, and estrogen levels increased in PCOS mice, but decreased following SPE and SPA treatment. In the PCOS mice, the reduced follicular-stimulating hormone (FSH) progesterone levels were restored to that of normal controls with SPE and SPA treatment in serum. The transcription level(s) of gonadotropin receptors (Fshr and Lhr), steroid receptors (Pgr, and Esr1), inflammatory markers (TNFα, IL1ß, IL6 and IL18), inflammatory-related factors (NF-κB, NF-κB p65, IκB) and antioxidant enzymes (GPx, SOD, CAT, GST, and GSH) changed under the PCOS condition. Moreover, they were regulated by SPE and SPA treatment in PCOS mice ovaries. The reproductive tissues of TE induced PCOS mice were restored into estrogenic conditions from androgen environments. The study of antioxidant activity of SPE and SPA using FRAP and DPPH tests showed high antioxidant activity. CONCLUSION: These results suggest that SPE and SPA ameliorates symptoms of PCOS by improving dysregulation of ovarian steroids, steroidogenic, antioxidant enzymes and inflammatory markers in PCOS mice.


Subject(s)
Crocus , Estrogens/blood , Luteinizing Hormone/blood , Ovary , Plant Extracts , Polycystic Ovary Syndrome , Testosterone/blood , Animals , Anthocyanins/pharmacology , Anti-Inflammatory Agents/pharmacology , Antioxidants/pharmacology , Disease Models, Animal , Drug Monitoring , Ethnopharmacology/methods , Female , Mice , Ovary/drug effects , Ovary/metabolism , Plant Extracts/chemistry , Plant Extracts/pharmacology , Polycystic Ovary Syndrome/drug therapy , Polycystic Ovary Syndrome/immunology , Polycystic Ovary Syndrome/metabolism
7.
Reprod Sci ; 29(2): 540-556, 2022 02.
Article in English | MEDLINE | ID: mdl-34591290

ABSTRACT

Hypertension has been implicated as a risk factor of reproductive disorders. High blood pressure may trigger impaired sperm quality and biomarkers of reproductive disorders. This study aims to investigate the effect of diet supplemented with Chrysophyllum albidum fruit pulp (FP) on sperm parameters, reproductive hormones, and antioxidant markers in testes and epididymis of hypertensive rats. Male Wistar rats were divided into seven groups (n = 10): normotensive control rats [NC], cyclosporine (25 mg/kg)-induced hypertensive rats [Hypert], hypertensive rats treated with captopril (10 mg/kg/day) [Hypert + Capt], hypertensive [Hypert + 2%FP and Hypert + 4%FP], and normotensive [2%FP and 4%FP] rats treated with 2% and 4% of diet supplemented with African star apple fruit's pulp [FP]. Hemodynamic parameters (arterial pressure, diastolic, and systolic pressure), sperm count, sperm motility, reproductive hormones, reactive oxygen species, and malondialdehyde levels were assessed. Diet supplemented with FP fed to hypertensive rats reduced mean arterial pressure, diastolic and systolic blood pressure, and heart rate. Furthermore, FP improved sperm quality in hypertensive rats by increasing sperm count, sperm motility with a concomitant reduction in sperm abnormality. FP also increased 3ß and 17ß-hydroxysteroid hydrogenase (3ß-HSD and 17ß -HSD) activities, as well as testosterone, luteinizing hormone, and follicle-stimulating hormone levels. Besides, FP triggered a significant increase in 3ß-HSD, 17ß -HSD, and STAR expression in rats' testicular tissues. Diet supplemented with FP also reduced ROS and malondialdehyde levels and triggered an increase in thiol levels, catalase, and glutathione-S-transferase activities. This study revealed that FP supplemented diet improved sexual function in cyclosporine-induced hypertensive rats by reducing blood pressure and modulation of sperm parameters, steroidogenic enzymes, and reproductive hormones.


Subject(s)
Dietary Supplements , Fruit , Hypertension/complications , Infertility, Male/etiology , Phytotherapy/methods , Sapotaceae , Animals , Epididymis/drug effects , Epididymis/metabolism , Follicle Stimulating Hormone/blood , Infertility, Male/drug therapy , Luteinizing Hormone/blood , Male , Rats , Rats, Wistar , Spermatozoa/drug effects , Testis/drug effects , Testis/metabolism , Testosterone/blood
8.
Biomed Pharmacother ; 145: 112359, 2022 Jan.
Article in English | MEDLINE | ID: mdl-34887141

ABSTRACT

This study assessed the fertility potential of methanol leaf extract of Glyphaea brevis (MGB) in rats exposed to 1,4-Dinitrobenzene (DNB), an environmental reprotoxicant. Male Wistar rats were orally exposed to 50 mg/kg DNB and administered 750 mg/kg MGB, 1500 mg/kg MGB or 300 mg/kg vitamin E for 21 days after 48 h of DNB exposure. Determination of serum reproductive hormone levels by enzyme-linked immunosorbent assays, evaluation of hematologic profile, computer-assisted sperm analyses (CASA) of sperm kinematics and morphology, assessment of testicular and spermatozoan antioxidant systems, and histopathological evaluation of reproductive tissues were performed. HPLC-DAD analysis identify Glyphaeaside C as the major component of the extract. In rats toxified with 50 mg/kg DNB, testicular and epididymal weights, serum levels of luteinizing hormone, testosterone and follicle-stimulating hormone, and packed cell volume, haemoglobin concentration, and white blood cell counts were decreased. There was altered sperm kinematics which reflected in increased sperm abnormalities. Treatment with the Glyphaeaside C -enriched MGB counteracted all DNB-induced changes and corrected DNB-induced aberrations in kinematic endpoints. Also, testicular and epididymal antioxidant systems were disrupted and there was damage to tissue histoarchitecture. Furthermore, our molecular docking study revealed that Glyphaeaside-C exhibited high binding affinities to the binding pocket of some free radical generating enzymes. Conclusively, the results indicated that Glyphaeaside C-enriched extract of Glyphaea brevis leaf enhanced the quality of semen and improved the functional capabilities of spermatozoa following exposure of rats to DNB which could translate to enhanced fertility.


Subject(s)
Antioxidants/metabolism , Imino Sugars/pharmacology , Malvaceae/chemistry , Plant Extracts/pharmacology , Animals , Dinitrobenzenes , Dose-Response Relationship, Drug , Follicle Stimulating Hormone/blood , Imino Sugars/administration & dosage , Luteinizing Hormone/blood , Male , Molecular Docking Simulation , Plant Extracts/administration & dosage , Plant Extracts/chemistry , Rats , Rats, Wistar , Reproduction/drug effects , Spermatozoa/drug effects , Testis/drug effects , Testosterone/blood
9.
J Ovarian Res ; 14(1): 173, 2021 Dec 11.
Article in English | MEDLINE | ID: mdl-34895279

ABSTRACT

INTRODUCTION: The hypothalamic-pituitary-ovarian (HPO) axis is the principal regulator of the reproductive system. The neurons in the arcuate nucleus of the hypothalamus signal the basophilic cells of the anterior pituitary to release luteinizing hormone (LH) and follicle stimulating hormone (FSH), which bind to the granulosa and theca cells of a follicle in the ovary to promote healthy follicular development. Disruption of this process at any time can lead to polycystic ovaries and, if left untreated, can lead to Polycystic Ovarian Syndrome (PCOS), one of the leading causes of infertility. A novel treatment option using 150 kHz Intermediate Frequency (IF) Electromagnetic Radiation (EMR) has been proposed to monitor the effect of this frequency during cystic development. METHODS: To prove this, an experiment was conducted to study the effect of whole-body exposure to 150 kHz EMR for 8 weeks at receptor, cellular, tissue and hormonal levels on the HPO axis of 25 young cyclic female rats. RESULTS: The results showed that 150 kHz EMR did not affect the histoarchitecture of neurons of arcuate nucleus of the hypothalamus of PCO-induced rats. It was also found that the number of basophilic cells of the pituitary gland was increased and the immunoreactivity of LH and FSH secretion increased. This EMR field also decreased the development of follicular cysts in the ovary and possibly increased the immunoreactivity of the LH and FSH receptors as well on the theca and granulosa cells of follicles in the ovary. CONCLUSION: There are still many limitations to this study. If properly evaluated, the results of this experiment could help develop a new non-invasive treatment option for women with PCOS in the near future.


Subject(s)
Magnetic Field Therapy , Polycystic Ovary Syndrome/therapy , Animals , Disease Models, Animal , Electromagnetic Radiation , Estradiol , Female , Follicle Stimulating Hormone/blood , Follicle Stimulating Hormone/metabolism , Hypothalamus/metabolism , Hypothalamus/pathology , Luteinizing Hormone/blood , Luteinizing Hormone/metabolism , Neurons/cytology , Ovary/metabolism , Ovary/pathology , Pituitary Gland/metabolism , Pituitary Gland/pathology , Polycystic Ovary Syndrome/chemically induced , Polycystic Ovary Syndrome/metabolism , Polycystic Ovary Syndrome/pathology , Rats, Sprague-Dawley , Receptors, FSH/metabolism , Receptors, LH/metabolism
10.
BMC Complement Med Ther ; 21(1): 291, 2021 Nov 29.
Article in English | MEDLINE | ID: mdl-34844580

ABSTRACT

BACKGROUND: Insulin resistance and hormonal imbalances are key features in the pathophysiology of polycystic ovarian syndrome (PCOS). We have previously shown that Ficus deltoidea var. deltoidea Jack (Moraceae) can improve insulin sensitivity and hormonal profile in PCOS female rats. However, biological characteristics underpinning the therapeutic effects of F. deltoidea for treating PCOS remain to be clarified. This study aims to investigate the biochemical, hormonal, and histomorphometric changes in letrozole (LTZ)-induced PCOS female rats following treatment with F. deltoidea. METHODS: PCOS was induced in rats except for normal control by administering LTZ at 1 mg/kg/day for 21 days. Methanolic extract of F. deltoidea leaf was then orally administered to the PCOS rats at the dose of 250, 500, or 1000 mg/kg/day, respectively for 15 consecutive days. Lipid profile was measured enzymatically in serum. The circulating concentrations of reproductive hormone and antioxidant enzymes were determined by ELISA assays. Ovarian and uterus histomorphometric changes were further observed by hematoxylin and eosin (H&E) staining. RESULTS: The results showed that treatment with F. deltoidea at the dose of 500 and 1000 mg/kg/day reduced insulin resistance, obesity indices, total cholesterol, triglycerides, low-density lipoprotein cholesterol (LDL), malondialdehyde (MDA), testosterone, luteinizing hormone (LH), and follicle-stimulating hormone (FSH) to near-normal levels in PCOS rats. The levels of high-density lipoprotein cholesterol (HDL), estrogen, and superoxide dismutase (SOD) are also similar to those observed in normal control rats. Histomorphometric measurements confirmed that F. deltoidea increased the corpus luteum number and the endometrial thickness. CONCLUSIONS: F. deltoidea can reverse PCOS symptoms in female rats by improving insulin sensitivity, antioxidant activities, hormonal imbalance, and histological changes. These findings suggest the potential use of F. deltoidea as an adjuvant agent in the treatment program of PCOS.


Subject(s)
Antioxidants/therapeutic use , Ficus , Hormones/metabolism , Insulin Resistance , Lipids/blood , Phytotherapy , Polycystic Ovary Syndrome/drug therapy , Animals , Antioxidants/pharmacology , Blood Glucose/metabolism , Corpus Luteum/drug effects , Disease Models, Animal , Endometrium/drug effects , Female , Follicle Stimulating Hormone/blood , Insulin/metabolism , Letrozole , Luteinizing Hormone/blood , Malondialdehyde/blood , Obesity , Plant Extracts/pharmacology , Plant Extracts/therapeutic use , Plant Leaves , Polycystic Ovary Syndrome/metabolism , Polycystic Ovary Syndrome/pathology , Rats, Sprague-Dawley , Testosterone/blood
11.
Ital J Pediatr ; 47(1): 210, 2021 Oct 23.
Article in English | MEDLINE | ID: mdl-34688301

ABSTRACT

OBJECTIVE: Recently, we observed some cases of Precocious Puberty (PP) with a partial central activation of hypothalamic-pituitary-gonadal (HPG) axis that tended to normalized in 6-12 months. To evaluate the frequency of this form within the spectrum of forms of PP, we retrospectively assessed the clinical, hormonal and ultrasound characteristics of patients attending to our Center for signs of PP, between 2007 and 2017. To hypothesize some causes of this "pubertal poussée" a questionnaire about environmental data was provided to patients. METHODS: 96 girls were recruited for the study and divided into three Groups. Group 1: 56 subjects with Central PP (CPP) requiring treatment with GnRH analogue; Group 2: 22 subjects with transient activation of pubertal axis, that tended to normalize, "Transient CPP"(T-CPP); Group 3: 18 subjects with Isolated Thelarche (IT). RESULTS: Mean age at diagnosis was 6.8 ± 1.0 years in Group 1, 5.9 ± 1.3 years in Group 2 and 5.6 ± 1.5 years in Group 3. A significant increase of diagnosis of T-CPP was observed over the study period. Significantly higher use of some homeopathic medicines and potential exposure to pesticides was reported in Group 2 vs Group 1. CONCLUSIONS: To our knowledge, we first reported a form defined as T-CPP, characterized by partial activation in the HPG axis normalizing over time. An increased use of homeopathic medicines and exposure to environmental pollutants in these patients was evidenced.


Subject(s)
Puberty, Precocious/diagnosis , Child , Estradiol/blood , Female , Follicle Stimulating Hormone/blood , Gonadotropin-Releasing Hormone/analogs & derivatives , Humans , Luteinizing Hormone/blood , Retrospective Studies , Triptorelin Pamoate/administration & dosage , Ultrasonography , Uterus/diagnostic imaging
12.
Sci Rep ; 11(1): 18824, 2021 09 22.
Article in English | MEDLINE | ID: mdl-34552120

ABSTRACT

Akt and nuclear factor kappa B (NF-κB) signaling pathways are involved in germ cell apoptosis and inflammation after testicular heat stress (THS). We observed that after THS induced by the exposure of rat testes to 43 °C for 20 min, their weight decreased, the fraction of apoptotic testicular germ cells significantly increased, and the proliferation of germ cells was inhibited. In addition, THS lowered serum testosterone (T) level, whereas the levels of follicle stimulating hormone and luteinizing hormone were not significantly changed. The ultrastructure of the seminiferous tubules became abnormal after THS, the structure of the blood-testis barrier (BTB) became loose, and the Sertoli cells showed a trend of differentiation. The level of phosphorylated Akt was reduced, whereas the amount of phosphorylated NF-κB p65 was augmented by THS. Wuzi-Yanzong (WZYZ), a classic Chinese medicine prescription for the treatment of male reproductive dysfunctions, alleviated the changes induced by THS. In order to determine the mechanism of action of WZYZ, we investigated how this preparation modulated the levels of T, androgen receptor (AR), erythropoietin (EPO), EPO receptor, and Tyro-3, Axl, and Mer (TAM) family of tyrosine kinase receptors. We found that WZYZ activated the Akt pathway, inhibited the Toll-like receptor/MyD88/NF-κB pathway, and repaired the structure of BTB by regulating the levels of T, AR, TAM receptors, and EPO. In conclusion, these results suggest that WZYZ activates the Akt pathway and inhibits the NF-κB pathway by acting on the upstream regulators, thereby improving spermatogenesis deficit induced by THS.


Subject(s)
Drugs, Chinese Herbal/therapeutic use , NF-kappa B/metabolism , Proto-Oncogene Proteins c-akt/metabolism , Signal Transduction/drug effects , Spermatogenesis/drug effects , Animals , Follicle Stimulating Hormone/blood , Heat-Shock Response , Luteinizing Hormone/blood , Male , Rats , Rats, Wistar , Sertoli Cells/drug effects , Testosterone/blood
13.
Reprod Biol Endocrinol ; 19(1): 102, 2021 Jul 05.
Article in English | MEDLINE | ID: mdl-34225767

ABSTRACT

OBJECTIVE: Evaluate the effects of vitamin D3 (VD3) on sperm parameters and endocrine markers in infertile men with asthenozoospermia. MATERIALS AND METHODS: This randomized, triple-masking, placebo-controlled clinical trial conducted on 86 asthenozoospermia infertile men with serum 25 hydroxy vitamin D3 (25(OH)VD3) < 30 ng/ml in the infertility clinic of Ahvaz Jahad daneshgahi, Iran. Patients were randomly allocated to groups A and B, who received daily 4000 IU VD3 and matching placebo respectively for 3 months. Demographic data, dietary intake, physical activity, sun exposure, anthropometric indices, serum 25(OH)VD3, luteinizing hormone (LH), follicle-stimulating hormone (FSH), total testosterone (T), estradiol (E2),, sex hormone-binding globulin (SHBG), free androgen index (FAI = T/SHBG. 100), T/LH and T/E2 ratios, prolactin (PRO), parathyroid hormone (PTH), osteocalcin (OCN), phosphorus and sperm parameters were assessed. RESULTS: Three months VD3 supplementation with 4000 IU/day had no significant effects body weight, body mass index (BMI), waist circumference (WC), body fat (BF), serum, OCN, LH, FSH, T, E2, SHBG, PRO, T/E2 ratio, FAI, semen volume, sperm count and normal sperm morphology. It increases serum 25(OH)VD3, PTH and phosphorus and seminal and serum calcium, T/LH ratio and total and progressive sperm motility and decreased significantly compared to the baseline and placebo group. CONCLUSION: VD3 supplementation may affect sperm motility in men with asthenozoospermia and serum 25(OH)VD3 < 30 ng/ml. TRIAL REGISTRATION: Iran Clinical Trials Registry, ID: IRCT20151128025274N4, registered on 28 March 2018, URL of trial registry record: https://www.irct.ir/trial/29983.


Subject(s)
Asthenozoospermia/drug therapy , Cholecalciferol/administration & dosage , Dietary Supplements , Infertility, Male/drug therapy , Sperm Motility/drug effects , Adult , Asthenozoospermia/blood , Asthenozoospermia/diagnosis , Cholecalciferol/blood , Double-Blind Method , Follow-Up Studies , Humans , Infertility, Male/blood , Infertility, Male/diagnosis , Luteinizing Hormone/blood , Male , Parathyroid Hormone/blood , Semen/drug effects , Semen/metabolism , Sperm Motility/physiology , Testosterone/blood , Treatment Outcome
14.
Nutrients ; 13(5)2021 May 15.
Article in English | MEDLINE | ID: mdl-34063339

ABSTRACT

Polycystic ovary syndrome (PCOS) is a heterogenous disorder characterized by chronic ovulation dysfunction and hyperandrogenism. It is considered the most common endocrinological disorder, affecting up to 25% of women of reproductive age, and associated with long-term metabolic abnormalities predisposing to cardiovascular risk, such as insulin resistance (IR), dyslipidemia, endothelial dysfunction, and systemic inflammation. PCOS is also characterized by elevated serum levels of luteinizing hormone (LH), causing a condition of hyperandrogenism and a consequent altered ratio between LH and the follicle stimulating hormone (FSH). Over the years, several different approaches have been proposed to alleviate PCOS symptoms. Supplementation with natural molecules such as inositols, resveratrol, flavonoids and flavones, vitamin C, vitamin E and vitamin D, and omega-3 fatty acids may contribute to overcoming PCOS pathological features, including the presence of immature oocyte, IR, hyperandrogenism, oxidative stress and inflammation. This review provides a comprehensive overview of the current knowledge about the efficacy of natural molecule supplementation in the management of PCOS.


Subject(s)
Polycystic Ovary Syndrome/blood , Polycystic Ovary Syndrome/drug therapy , Ascorbic Acid , Dietary Supplements , Dyslipidemias/complications , Fatty Acids, Omega-3 , Female , Flavanones , Flavonoids , Follicle Stimulating Hormone/blood , Humans , Hyperandrogenism/complications , Inositol , Insulin Resistance , Luteinizing Hormone/blood , Ovulation , Resveratrol , Vitamin D , Vitamin E , Vitamins
15.
J Clin Endocrinol Metab ; 106(9): 2635-2645, 2021 08 18.
Article in English | MEDLINE | ID: mdl-34013335

ABSTRACT

CONTEXT: Soy formula feeding is common in infancy and is a source of high exposure to phytoestrogens, documented to influence vaginal cytology in female infants. Its influence on minipuberty in males has not been established. OBJECTIVE: To assess the association between infant feeding practice and longitudinally measured reproductive hormones and hormone-responsive tissues in infant boys. METHODS: The Infant Feeding and Early Development study was a prospective cohort of maternal-infant dyads requiring exclusive soy formula, cow milk formula, or breast milk feeding during study follow-up. In the 147 infant boy participants, serum testosterone, luteinizing hormone, stretched penile length, anogenital distance, and testis volume were longitudinally assessed from birth to 28 weeks. We examined feeding-group differences in age trajectories for these outcomes using mixed-effects regression splines. RESULTS: Median serum testosterone was at pubertal levels at 2 weeks (176 ng/dL [quartiles: 124, 232]) and remained in this range until 12 weeks in all feeding groups. We did not observe differences in trajectories of hormone concentrations or anatomical measures between boys fed soy formula (n = 55) and boys fed cow milk formula (n = 54). Compared with breastfed boys (n = 38), soy formula-fed boys had a more rapid increase in penile length (P = .004) and slower initial lengthening of anogenital distance (P = .03), but no differences in hormone trajectories. CONCLUSION: Reproductive hormone concentrations and anatomical responses followed similar trajectories in soy and cow milk formula-fed infant boys. Our findings suggest that these measures of early male reproductive development do not respond to phytoestrogen exposure during infancy.


Subject(s)
Genitalia, Male/anatomy & histology , Glycine max , Infant Formula , Phytoestrogens/pharmacology , Testosterone/blood , Adult , Breast Feeding , Female , Humans , Infant , Luteinizing Hormone/blood , Male , Penis/anatomy & histology , Penis/growth & development , Prospective Studies , Testis/anatomy & histology
16.
Biomed Pharmacother ; 140: 111760, 2021 Aug.
Article in English | MEDLINE | ID: mdl-34052566

ABSTRACT

The global prevalence of diabetes mellitus is rapidly increasing. This disease is associated with many complications including male reproductive dysfunctions and infertility. Seahorse ( Hippocampus kuda) is a marine teleost fish well known for its beneficial effects on the reproductive system in traditional Chinese medicine books. Recently, several studies have been shown that the enzymatic hydrolysate of seahorse has multiple pharmacological activities. This study aimed to investigate the seahorse peptide hydrolysate (SH) ameliorative effects on the diabetic-induced male reproductive dysfunction in rat models. The in vivo studies were carried out with three different doses of SH (4, 8, and 20 mg/kg) and the diabetes condition was induced by administrating with streptozotocin (35 mg/kg) and fed a 40% high-fat diet. Seahorse hydrolysate (20 mg/kg) inhibited lipid peroxidation, increased antioxidant enzyme activity, and restored seminiferous tubules morphology in testis. Moreover, it improved reproductive dysfunction by increasing the level of testosterone, follicle-stimulating hormone, luteinizing hormone, sperm count, and motility. According to these results, we suggested that SH exhibited amelioration effects on the reproductive dysfunction.


Subject(s)
Diabetes Mellitus, Experimental/drug therapy , Fish Proteins , Protein Hydrolysates/therapeutic use , Reproduction/drug effects , Smegmamorpha , Animals , Blood Glucose/drug effects , Blood Glucose/immunology , Cytokines/immunology , Diabetes Mellitus, Experimental/blood , Diabetes Mellitus, Experimental/pathology , Follicle Stimulating Hormone/blood , Luteinizing Hormone/blood , Male , Oxidative Stress/drug effects , Protein Hydrolysates/pharmacology , Rats, Sprague-Dawley , Sperm Count , Sperm Motility/drug effects , Spermatozoa/abnormalities , Spermatozoa/drug effects , Testis/drug effects , Testis/pathology , Testosterone/blood
17.
J Endocrinol Invest ; 44(12): 2785-2797, 2021 Dec.
Article in English | MEDLINE | ID: mdl-33970435

ABSTRACT

PURPOSE: Organic conditions underlying secondary hypogonadism (SH) may be ascertained by magnetic resonance imaging (MRI) of the hypothalamic-pituitary region that could not be systematically proposed to each patient. Based upon limited evidence, the Endocrine Society (ES) guidelines suggest total testosterone (T) < 5.2 nmol/L to identify patients eligible for MRI. The study aims to identify markers and their best threshold value predicting pathological MRI findings in men with SH. METHODS: A consecutive series of 609 men seeking medical care for sexual dysfunction and with SH (total T < 10.5 nmol/L and LH ≤ 9.4 U/L) was retrospectively evaluated. An independent cohort of 50 men with SH was used as validation sample. 126 men in the exploratory sample and the whole validation sample underwent MRI. RESULTS: In the exploratory sample, patients with pathological MRI findings (n = 46) had significantly lower total T, luteinizing hormone (LH), follicle stimulating hormone (FSH) and prostate specific antigen (PSA) than men with normal MRI (n = 80). Receiver Operating Characteristics analysis showed that total T, LH, FSH and PSA are accurate in identifying men with pathologic MRI (accuracy: 0.62-0.68, all p < 0.05). The Youden index was used to detect the value with the best performance, corresponding to total T 6.1 nmol/L, LH 1.9 U/L, FSH 4.2 U/L and PSA 0.58 ng/mL. In the validation cohort, only total T ≤ 6.1 nmol/L and LH ≤ 1.9 U/L were confirmed as significant predictors of pathologic MRI. CONCLUSION: In men with SH, total T ≤ 6.1 nmol/L or LH ≤ 1.9 U/L should arise the suspect of hypothalamus/pituitary structural abnormalities, deserving MRI evaluation.


Subject(s)
Eunuchism , Follicle Stimulating Hormone , Hypothalamus , Luteinizing Hormone , Magnetic Resonance Imaging/methods , Pituitary Gland , Sexual Dysfunction, Physiological , Testosterone , Eligibility Determination , Eunuchism/blood , Eunuchism/complications , Eunuchism/diagnosis , Follicle Stimulating Hormone/analysis , Follicle Stimulating Hormone/blood , Humans , Hypothalamus/abnormalities , Hypothalamus/diagnostic imaging , Italy/epidemiology , Luteinizing Hormone/analysis , Luteinizing Hormone/blood , Male , Middle Aged , Pituitary Gland/abnormalities , Pituitary Gland/diagnostic imaging , Sexual Dysfunction, Physiological/diagnosis , Sexual Dysfunction, Physiological/epidemiology , Sexual Dysfunction, Physiological/etiology , Testosterone/analysis , Testosterone/blood
18.
Life Sci ; 277: 119575, 2021 Jul 15.
Article in English | MEDLINE | ID: mdl-33961859

ABSTRACT

Sexual function is essential for species survival. Melanocortin, progesterone, and estrogen can improve sexual function and they are modulated by adiponectin hormone which can be increased by Turmeric. In various studies shows Turmeric ability that is easily accessible to increase serum adiponectin levels. Therefore, the researchers decided to conduct a study to determine the effect of turmeric on serum adiponectin levels, sexual behavior, and profile of steroid hormones in stressed mice. Thirty female mice, six in each group (1. control group, 2. mice that received stress, 3. stress mice received 100 mg/kg turmeric (extract daily) for 4 weeks, 4. stress mice received turmeric (extract daily) for 4 weeks and also received adiponectin antagonist, and 5. stress groups received adiponectin antagonist), were used in the current study. The mice first underwent blood sampling. Then all mice were subjected to stress testing before the intervention except one group, which considered as a control group. The intervention in this study was done as a 100 mg/kg turmeric extract that was gavaged daily for each mouse. After the intervention, all mice were tested for sexual behavior, and then blood samples were taken to check serum levels of adiponectin, estradiol, progesterone and prolactin. So, the results showed before the intervention there were no significant difference among 5 group in levels of adiponectin (p = 0.145), estradiol (p = 0.148), progesterone (p = 0.166) and prolactin (p = 0.206) but after intervention there were significant difference between 5 group in levels of adiponectin, estradiol and progesterone (p < 0.001). Also there was significant difference among 5 groups in sexual behavior (p < 0.001). Therefore, consumption of turmeric, which increases serum adiponectin in the stressed mice, can improve sexual function and estradiol hormones profiling.


Subject(s)
Curcuma/metabolism , Gonadal Steroid Hormones/metabolism , Plant Extracts/pharmacology , Adiponectin/metabolism , Animals , Estradiol/analysis , Estradiol/blood , Female , Follicle Stimulating Hormone/analysis , Follicle Stimulating Hormone/blood , Luteinizing Hormone/analysis , Luteinizing Hormone/blood , Mice , Mice, Inbred C57BL , Progesterone/analysis , Progesterone/blood , Prolactin/analysis , Prolactin/blood , Sexual Behavior/physiology , Stress, Physiological/drug effects
19.
Mol Reprod Dev ; 88(6): 405-415, 2021 06.
Article in English | MEDLINE | ID: mdl-34032349

ABSTRACT

The effect of stress on male fertility is a widespread public health issue, but less is known about the related signaling pathway. To investigate this, we established a hypercortisolism mouse model by supplementing the drinking water with corticosterone for four weeks. In the hypercortisolism mice, the serum corticosterone was much higher than in the control, and serum testosterone was significantly decreased. Moreover, corticosterone treatment induced decrease of sperm counts and increase of teratozoospermia. Increased numbers of multinucleated giant cells and apoptotic germ cells as well as downregulated meiotic markers suggested that corticosterone induced impaired spermatogenesis. Further, upregulation of macrophage-specific marker antigen F4/80 as well as inflammation-related genes suggested that corticosterone induced inflammation in the testis. Lactate content was found to be decreased in the testis and Sertoli cells after corticosterone treatment, and lactate metabolism-related genes were downregulated. In vitro phagocytosis assays showed that the phagocytic activity in corticosterone-treated Sertoli cells was downregulated and accompanied by decreased mitochondrial membrane potential, while pyruvate dehydrogenase kinase-4 inhibitor supplementation restored this process. Taken together, our results demonstrated that dysfunctional phagocytosis capacity and lactate metabolism in Sertoli cells participates in corticosterone-induced impairment of spermatogenesis.


Subject(s)
Glucocorticoids/toxicity , Sertoli Cells/physiology , Spermatogenesis/drug effects , Animals , Calcium-Binding Proteins/analysis , Corticosterone/toxicity , Cushing Syndrome/blood , Cushing Syndrome/chemically induced , Cushing Syndrome/physiopathology , Dichloroacetic Acid/pharmacology , Follicle Stimulating Hormone/blood , Lactic Acid/metabolism , Luteinizing Hormone/blood , Male , Meiosis/drug effects , Membrane Potential, Mitochondrial/drug effects , Mice , Orchitis/chemically induced , Orchitis/metabolism , Phagocytosis/drug effects , Pyruvate Dehydrogenase Acetyl-Transferring Kinase/antagonists & inhibitors , Receptors, G-Protein-Coupled/analysis , Sertoli Cells/metabolism , Sperm Count , Spermatozoa/pathology , Testis/metabolism , Testosterone/blood
20.
Molecules ; 26(6)2021 Mar 18.
Article in English | MEDLINE | ID: mdl-33803601

ABSTRACT

Hypogonadism, associated with low levels of testosterone synthesis, has been implicated in several diseases. Recently, the quest for natural alternatives to prevent and treat hypogonadism has gained increasing research interest. To this end, the present study explored the effect of S-allyl cysteine (SAC), a characteristic organosulfur compound in aged-garlic extract, on testosterone production. SAC was administered at 50 mg/kg body weight intraperitoneally into 7-week-old BALB/c male mice in a single-dose experiment. Plasma levels of testosterone and luteinizing hormone (LH) and testis levels of proteins involved in steroidogenesis were measured by enzymatic immunoassay and Western blot, respectively. In addition, mouse testis-derived I-10 cells were also used to investigate the effect of SAC on steroidogenesis. In the animal experiment, SAC significantly elevated testosterone levels in both the plasma and the testis without changing the LH level in plasma and increased phosphorylated protein kinase A (p-PKA) levels. Similar results were also observed in I-10 cells. The findings demonstrating the increasing effect of SAC on p-PKA and mRNA levels of Cyp11a suggest that SAC increases the testosterone level by activating the PKA pathway and could be a potential target for hypogonadism therapeutics.


Subject(s)
Cysteine/analogs & derivatives , Testis/drug effects , Testis/metabolism , Testosterone/biosynthesis , Animals , Cell Line , Cyclic AMP-Dependent Protein Kinases/metabolism , Cysteine/pharmacology , Enzyme Activation/drug effects , Garlic/chemistry , Leydig Cells/drug effects , Leydig Cells/metabolism , Luteinizing Hormone/blood , Male , Mice , Mice, Inbred BALB C , Phosphorylation , Testis/cytology , Testosterone/blood
SELECTION OF CITATIONS
SEARCH DETAIL